Group One Trading, L.P. Pharma Cyte Biotech, Inc. Transaction History

Group One Trading, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$2.74 - $3.18 $274 - $318	-100 Reduced 0.7%	14,282 $40,000
Q1 2023 May 12, 2023	BUY	$2.83 - $3.03 $40,701 - $43,577	14,382 New	14,382 $41,000
Q3 2022 Nov 09, 2022	BUY	$2.24 - $2.85 $13,464 - $17,131	6,011 Added 8.71%	75,052 $180,000
Q2 2022 Aug 11, 2022	BUY	$1.99 - $2.33 $137,391 - $160,865	69,041 New	69,041 $156,000

1.12M

Ticker PMCB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,750,100
Market Cap $36.7M
Description
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.